Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amsacrine (AMSA)--a clinical review.

× No keyword cloud information.

12 in total

Review 1. [Antineoplastic drug-induced extravasation].

Authors: Maike de Wit
Journal: Med Klin (Munich) Date: 2010-11

2. Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: a potentiating role for amsacrine.

Authors: L T Vlasveld; F E Zwaan; W E Fibbe; R T Tjon; T A Tham; P M Kluin; R Willemze
Journal: Ann Hematol Date: 1991-04 Impact factor: 3.673

3. Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes.

Authors: Elisângela A M Mendonça; Mariane C B Lira; Marcelo M Rabello; Isabella M F Cavalcanti; Suely L Galdino; Ivan R Pitta; Maria do Carmo A Lima; Maira G R Pitta; Marcelo Z Hernandes; Nereide S Santos-Magalhães
Journal: AAPS PharmSciTech Date: 2012-10-02 Impact factor: 3.246

Review 4. DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.

Authors: Carlos García-Estrada; Christopher Fernández Prada; Celia Fernández-Rubio; Francisco Rojo-Vázquez; Rafael Balaña-Fouce
Journal: Proc Biol Sci Date: 2010-03-03 Impact factor: 5.349

5. Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study.

Authors: C P Steuber; T Holbrook; B Camitta; V J Land; C Sexauer; J Krischer
Journal: Invest New Drugs Date: 1991-05 Impact factor: 3.850

Amsacrine (AMSA)--a clinical review.

Review 1. [Antineoplastic drug-induced extravasation].

2. Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: a potentiating role for amsacrine.

3. Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes.

Review 4. DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.

5. Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study.

Review 6. Cancer chemotherapy and cardiac arrhythmias: a review.

7. Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma.

8. Inhibition of 7-hydroxymethotrexate formation by amsacrine.

9. Anthracycline dose intensification in young adults with acute myeloid leukemia.

10. CI-921: an analog of amsacrine with experimental activity against solid tumors.